Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol and substance use disorder: Dream or reality
Saeideh Karimi‐Haghighi, Yasaman Razavi, Daniela Iezzi, et al.
Neuropharmacology (2022) Vol. 207, pp. 108948-108948
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: The role of ER stress, oxidative stress, and neuroinflammation
Mohammad Sobhan Karvandi, Farzam Sheikhzadeh Hesari, Amir Reza Aref, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 45
Cannabidiol-Loaded Nanocarriers and Their Therapeutic Applications
Elham Assadpour, Atefe Rezaei, Sabya Sachi Das, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 487-487
Open Access | Times Cited: 22
Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
Advances in mitophagy and mitochondrial apoptosis pathway-related drugs in glioblastoma treatment
Weiping Li, Xia Xu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 16
In utero exposure to cannabidiol disrupts select early-life behaviors in a sex-specific manner
Daniela Iezzi, Alba Cáceres-Rodríguez, Pascale Chavis, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence
Bertrand Redonnet, Filiz Eren, Guillaume Avenin, et al.
Addiction (2025)
Open Access
Involvement of D2-like dopamine receptors within the ventral tegmental area in the cannabidiol's inhibitory effects on the methamphetamine-seeking behavior
Mohammad Javad Ezzati, Mohammad Ezzati, Mojdeh Fattahi, et al.
Physiology & Behavior (2025), pp. 114845-114845
Closed Access
Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review
Justin Matheson, Zoe Bourgault, Bernard Le Foll
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1462-1462
Open Access | Times Cited: 21
An Overview of Cannabidiol
Alexandra Sideris, Lisa Doan
Anesthesia & Analgesia (2023) Vol. 138, Iss. 1, pp. 54-68
Open Access | Times Cited: 9
The Development of Cannabinoids as Therapeutic Agents in the United States
Conor H. Murray, Brenda M. Gannon, Peter J. Winsauer, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 5, pp. 915-955
Open Access | Times Cited: 3
Investigating Cannabidiol’s Potential as a Supplementary Treatment for Schizophrenia: A Narrative Review
Jes Sebastian Denis Völker, I. Micluția, Ramona-Cristina Vinași
European Journal of Pharmacology (2024) Vol. 979, pp. 176821-176821
Closed Access | Times Cited: 3
Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review
Lindsay A. Lo, Caroline A. MacCallum, Kate Nanson, et al.
The Canadian Journal of Psychiatry (2023) Vol. 68, Iss. 8, pp. 557-571
Open Access | Times Cited: 8
Identification of the circRNA–miRNA–mRNA network for treating methamphetamine‐induced relapse and behavioral sensitization with cannabidiol
Liu Liu, Chan Wang, Haowei Wang, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 2
A review on the role of metabotropic glutamate receptors in neuroplasticity following psychostimulant use disorder
Roghayeh Mozafari, Saeideh Karimi‐Haghighi, Mojdeh Fattahi, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 124, pp. 110735-110735
Closed Access | Times Cited: 5
Enhanced brain-targeting and efficacy of cannabidiol via RVG-Exo/CBD nanodelivery system
Yingrui Li, Ze Chen, Jia Guo, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 725, pp. 150260-150260
Closed Access | Times Cited: 1
Promising immunomodulators for management of substance and alcohol use disorders
Amanda M. Acuña, Connor Park, Jonna M. Leyrer‐Jackson, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 7, pp. 867-884
Closed Access | Times Cited: 1
Endocannabinoid system as a therapeutic target for psychostimulants relapse: A systematic review of preclinical studies
Saeideh Karimi‐Haghighi, Maedeh Mahmoudi, Fatemeh Sayehmiri, et al.
European Journal of Pharmacology (2023) Vol. 951, pp. 175669-175669
Closed Access | Times Cited: 3
Identification of key genes and therapeutic drugs for cocaine addiction using integrated bioinformatics analysis
Xu Wang, Shibin Sun, Hongwei Chen, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 2
The Therapeutic Potential of Cannabidiol in Revolutionising Opioid Use Disorder Management
Kelvin Le, Joanne Au, Jean Hua, et al.
Cureus (2023)
Open Access | Times Cited: 2
Cannabidiol (CBD) facilitates cocaine extinction and ameliorates cocaine-induced changes to the gut microbiome in male C57BL/6JArc mice
Rose Chesworth, Howard Chi Ho Yim, Georgia Watt, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 133, pp. 111014-111014
Open Access
The Role of Medicinal Cannabis as an Emerging Therapy for Opioid Use Disorder
Kelvin Le, Khang Duy Ricky Le, Johnny Nguyen, et al.
Pain and Therapy (2024) Vol. 13, Iss. 3, pp. 435-455
Open Access
A Translational Approach to Using Endocannabinoid Modulators for Targeting Opioid-Associated Memory
Saeideh Karimi‐Haghighi, Roghayeh Mozafari, Sara Chavoshinezhad, et al.
Current Addiction Reports (2024) Vol. 11, Iss. 5, pp. 894-915
Closed Access
The role of D1-like dopamine receptors within the ventral tegmental area in the cannabidiol’s inhibitory effects on the methamphetamine-induced conditioned place preference in rats
Mohammad Ezzati, Mohammad Javad Ezzati, Mojdeh Fattahi, et al.
Brain Research Bulletin (2024) Vol. 216, pp. 111038-111038
Open Access
Cannabidiol Use Among Older Adults: Associations with Cannabis Use, Physical and Mental Health, and Other Substance Use
Namkee G. Choi, C. Nathan Marti, Bryan Y. Choi
Clinical Gerontologist (2024), pp. 1-13
Closed Access
Le cannabidiol (CBD) : que faut-il retenir ?
Jean‐Claude Alvarez, Anne-Laure Pelissier, Patrick Mura, et al.
Annales de Toxicologie Analytique (2022) Vol. 34, Iss. 4, pp. 211-214
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top